MENU
ELVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Enliven Therapeutics (ELVN) Ownership - Who owns Enliven Therapeutics?
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more
Profile
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
46
Web
https://www.enliventherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.06B
P/E Ratio
N/A
Total Cash
289.56M
Projected Growth
N/A
Total Debt
365K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.91
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ELVN
Capitalization
1.06B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
290M
Total Cash/Share
4.91
Total Debt
365K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
288M
P/B Ratio
3.86
Cash Flow
N/A
Earnings
-1.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
49K
Current Ratio
21.06
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-109.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.39
Shares Held By Institutions
1.35B
Shares Outstanding - Current
59M
Total Liabilities
14.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.444
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELVN showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
46
Web
https://www.enliventherapeutics.com